CMV-specific HIV-CAR T Cells therapy(City Of Hope National Medical Center)

N/A

Report date: 2025/03/28 20:01:04

Base Information

Drug NameCMV-specific HIV-CAR T Cells therapy(City Of Hope National Medical Center)
Drug Alias NameCMV/HIV-CAR T Cells therapy(City Of Hope National Medical Center)Cytomegalovirus-Specific, Anti-HIV Chimeric Antigen Receptor (CMV-HIV CAR) T Cells therapy(City Of Hope National Medical Center)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionT lymphocyte replacementsCytomegalovirus pp65 Antigen modulators
TargetsCytomegalovirus pp65 Antigen
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCity Of Hope National Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesCity Of Hope National Medical Center
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A